Published in Clin Exp Immunol on May 01, 1983
Isolation and characterization of expression cDNA clones encoding antigens of Onchocerca volvulus infective larvae. J Clin Invest (1988) 1.28
Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment. Clin Exp Immunol (1992) 1.22
Pathogenesis of onchocercal keratitis (River blindness). Clin Microbiol Rev (1999) 1.20
Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection. Clin Exp Immunol (1994) 1.19
The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection. Immunology (1997) 1.06
Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers. Clin Exp Immunol (1999) 1.02
Clinical and laboratory aspects of filariasis. Clin Microbiol Rev (1989) 0.98
Role of helminths in regulating mucosal inflammation. Springer Semin Immunopathol (2005) 0.97
Immunoregulation in onchocerciasis. Functional and phenotypic abnormalities of lymphocyte subsets and changes with therapy. J Clin Invest (1991) 0.95
Suppression of human lymphocyte responses to specific and non-specific stimuli in human onchocerciasis. Clin Exp Immunol (1991) 0.94
Chronic helminth infection reduces basophil responsiveness in an IL-10-dependent manner. J Immunol (2012) 0.94
Unique recognition of a low molecular weight Onchocerca volvulus antigen by IgG3 antibodies in chronic hyper-reactive oncho-dermatitis (Sowda). Clin Exp Immunol (1988) 0.92
In utero exposure to Onchocerca volvulus: relationship to subsequent infection intensity and cellular immune responsiveness. Infect Immun (1996) 0.92
Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls. Immunology (1999) 0.89
Protective responses against skin-dwelling microfilariae of Onchocerca lienalis in severe combined immunodeficient mice. Infect Immun (1997) 0.88
Immunoregulation in experimental filariasis. IV. Induction of non-specific suppression following in vitro exposure of spleen cells from infected jirds to Brugia pahangi antigen. Immunology (1984) 0.85
Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy. Clin Exp Immunol (2007) 0.82
Increased activation and oligoclonality of peripheral CD8(+) T cells in the chronic human helminth infection alveolar echinococcosis. Infect Immun (2002) 0.81
Effect of cyclophosphamide on the immune responsiveness of jirds infected with Brugia pahangi. Infect Immun (1984) 0.80
The novel cuticular collagen Ovcol-1 of Onchocerca volvulus is preferentially recognized by immunoglobulin G3 from putatively immune individuals. Infect Immun (1997) 0.80
Neither primary nor memory immunity to Mycobacterium tuberculosis infection is compromised in mice with chronic enteric helminth infection. Infect Immun (2015) 0.79
Microfilariae of the filarial nematode Litomosoides sigmodontis exacerbate the course of lipopolysaccharide-induced sepsis in mice. Infect Immun (2008) 0.79
Comprehensive Transcriptome Meta-analysis to Characterize Host Immune Responses in Helminth Infections. PLoS Negl Trop Dis (2016) 0.75
A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem (1977) 36.95
Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med (1977) 4.59
Suppressor adherent cells in human tuberculosis. J Immunol (1978) 2.68
Specific cellular immune unresponsiveness in human filariasis. Immunology (1977) 2.23
Immune responses in human infections with Brugia malayi: specific cellular unresponsiveness to filarial antigens. J Clin Invest (1980) 1.68
Antigen-specific suppressor cells and suppressor factors in human filariasis with Brugia malayi. N Engl J Med (1980) 1.68
Tuberculin skin tests and B.C.G. vaccination in hyperendemic area of onchocerciasis. Lancet (1977) 1.55
Onchocerciasis: some new epidemiologic and clinical findings. Results of an epidemiologic study in the Republic of Chad. Am J Trop Med Hyg (1969) 1.50
Antigen-specific suppressor T lymphocytes in human lymphatic filariasis. N Engl J Med (1982) 1.47
Variation in delayed hypersensitivity in onchocerciasis. Trans R Soc Trop Med Hyg (1978) 1.42
Cellular killing of microfilariae of Onchocerca volvulus: eosinophil and neutrophil-mediated immune serum-dependent destruction. J Immunol (1981) 1.34
Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma. N Engl J Med (1977) 1.22
Feedback regulation of immune responses by immune complexes; possible involvement of a suppressive lymphokine by FcR gamma-bearing B cell. J Immunol (1982) 1.07
Circulating immune complexes in onchocerciasis. Clin Exp Immunol (1980) 0.99
Immunological studies on onchocerciasis. Varying skin hypersensitivity and leucocyte migration inhibition in a clinical spectrum of the disease. Acta Trop (1978) 0.98
What happens when microfilariae die? Trans R Soc Trop Med Hyg (1976) 0.91
Circulating antigen-antibody complexes in onchocerciasis. Clin Exp Immunol (1982) 0.89
Inflammatory reactions in onchocerciasis: a report on current knowledge and recommendations for further study. Bull World Health Organ (1979) 0.87
A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med (1997) 8.43
Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature (1992) 4.11
Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am J Epidemiol (2003) 3.09
Validity of sexual histories in a prospective study of male sexual contacts of men with AIDS or an AIDS-related condition. Am J Epidemiol (1988) 2.81
Suppressor adherent cells in human tuberculosis. J Immunol (1978) 2.68
Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol (1994) 2.52
Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot. Proc Natl Acad Sci U S A (1990) 2.46
Mycobacterium avium complex infection and AIDS: advances in theory and practice. Clin Infect Dis (1993) 2.39
Human immune response to Mycobacterium tuberculosis antigens. Infect Immun (1991) 2.39
Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS (2000) 2.32
Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. J Immunol (1991) 2.29
Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J Immunol (1995) 2.21
Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immun (1988) 2.21
Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. Proc Natl Acad Sci U S A (1996) 2.15
Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis. J Infect Dis (1993) 2.14
Infective endocarditis caused by slow-growing, fastidious, Gram-negative bacteria. Medicine (Baltimore) (1979) 2.09
Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis (1999) 2.06
Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens. J Immunol (1986) 2.05
Risk factors for HIV infection in male sexual contacts of men with AIDS or an AIDS-related condition. Am J Epidemiol (1988) 2.05
Drug tolerance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (1999) 1.94
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis. J Exp Med (1986) 1.88
Immunosuppression by mycobacterial arabinomannan. Clin Exp Immunol (1979) 1.87
The effect of bacille Calmette-Guérin vaccination at birth on tuberculin skin test reactivity in Ugandan children. Int J Tuberc Lung Dis (1999) 1.76
Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J Infect Dis (1994) 1.76
Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin Exp Immunol (1996) 1.76
A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.74
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. AIDS (2001) 1.73
Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda. J Clin Microbiol (2002) 1.72
Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy. Am J Respir Crit Care Med (1999) 1.67
Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol (2001) 1.67
A whole blood bactericidal assay for tuberculosis. J Infect Dis (2001) 1.65
The reliability of sexual histories in AIDS-related research: evaluation of an interview-administered questionnaire. Can J Public Health (1987) 1.60
Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis. J Clin Invest (1991) 1.60
In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc Natl Acad Sci U S A (1997) 1.53
Induction of transforming growth factor beta 1 by purified protein derivative of Mycobacterium tuberculosis. Infect Immun (1995) 1.52
Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet). J Infect Dis (1988) 1.52
Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon. Infect Immun (1989) 1.52
Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 1.51
Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness. J Clin Invest (1980) 1.48
Complications of percutaneous central venous catheterization: a report of two cases and review of the literature. Johns Hopkins Med J (1979) 1.46
Cytokines and tuberculosis. J Leukoc Biol (1994) 1.45
Suppression of antigen and mitogen induced human T lymphocyte DNA synthesis by bacterial lipopolysaccharide: mediation by monocyte activation and production of prostaglandins. J Immunol (1979) 1.45
Phytohemagglutinin-induced proliferation of guinea pig thymus-derived lymphocytes. I. Accessory cell dependence. J Immunol (1976) 1.45
Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis. J Infect Dis (1999) 1.44
Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis. J Infect Dis (2001) 1.43
Characterization of the autoantigen calreticulin. J Immunol (1991) 1.42
Risk factors for HIV infection in homosexual men: the Cleveland men's study of risks in a low-prevalence area. Cleve Clin J Med (1992) 1.41
Sexual behaviour changes in a cohort of male sexual contacts of men with HIV disease: a three-year overview. Can J Public Health (1991) 1.40
Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guérin in purified protein derivative (PPD)-positive individuals. J Immunol (1995) 1.40
Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect Immun (1996) 1.39
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Engl J Med (1985) 1.39
Delayed tuberculin reactivity in persons of Indochinese origin: implications for preventive therapy. Ann Intern Med (1996) 1.39
Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility. J Clin Invest (1981) 1.36
Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am Rev Respir Dis (1986) 1.35
Cellular killing of microfilariae of Onchocerca volvulus: eosinophil and neutrophil-mediated immune serum-dependent destruction. J Immunol (1981) 1.34
Failure of penicillin G benzathine in the treatment of neurosyphilis. Arch Intern Med (1980) 1.34
Induction of the antigen 85 complex of Mycobacterium tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatment. J Infect Dis (1998) 1.33
Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection: potential mechanisms of viral activation. J Acquir Immune Defic Syndr (2001) 1.29
Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis. Int J Tuberc Lung Dis (1997) 1.29
Isolation and characterization of expression cDNA clones encoding antigens of Onchocerca volvulus infective larvae. J Clin Invest (1988) 1.28
Pleural fluid and peripheral blood lymphocyte function in tuberculosis. Ann Intern Med (1978) 1.28
Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis. Antimicrob Agents Chemother (2001) 1.27
Haemophilus influenzae meningitis: the spectrum of disease in adults. Medicine (Baltimore) (1982) 1.27
Role of the mononuclear phagocyte as an antigen-presenting cell for human gamma delta T cells activated by live Mycobacterium tuberculosis. Infect Immun (1992) 1.26
A prospective study of male sexual contacts of men with AIDS-related conditions (ARC) or AIDS: HTLV-III antibody, clinical, and immune function status at induction. Can J Public Health (1986) 1.26
Antigen handling by guinea pig macrophages: further evidence for the sequestration of antigen relevant for activation of primed T lymphocytes. J Immunol (1977) 1.25
Chronic meningitis. Medicine (Baltimore) (1976) 1.25
Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. J Clin Invest (1990) 1.24
Anti-Mycobacterium avium activity of quinolones: in vitro activities. Antimicrob Agents Chemother (1993) 1.23
Role of cell-generated hydrogen peroxide in granulocyte-mediated killing of schistosomula of Schistosoma mansoni in vitro. J Clin Invest (1981) 1.22
Cell-mediated immune responses in human infection with Onchocerca volvulus. J Immunol (1988) 1.22
The role of TGF beta in the pathogenesis of human tuberculosis. Clin Immunol Immunopathol (1998) 1.21
Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community. J Immunol (2000) 1.20
A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions. Antimicrob Agents Chemother (1994) 1.19
A DNA sequence specific for forest form Onchocerca volvulus. Nature (1987) 1.18
Interaction of Mycobacterium tuberculosis-induced transforming growth factor beta1 and interleukin-10. Infect Immun (1999) 1.17
Strain- and donor-related differences in the interaction of Mycobacterium avium with human monocytes and its modulation by interferon-gamma. J Infect Dis (1990) 1.17
The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda. Am Rev Respir Dis (1991) 1.17
Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration. Int J Tuberc Lung Dis (1998) 1.16
Association of altered dynamics of monocyte surface expression of human leukocyte antigen DR with immunosuppression in tuberculosis. J Infect Dis (1984) 1.16
Histological examination of onchocercomata after therapy with ivermectin. Trop Med Parasitol (1988) 1.16
Predicting the outcome of therapy for pulmonary tuberculosis. Am J Respir Crit Care Med (2000) 1.15
Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science (1990) 1.14
The status of ivermectin in the treatment of human onchocerciasis. Am J Trop Med Hyg (1989) 1.14
Spectrum of immunoregulatory functions and properties of human alveolar macrophages. Am Rev Respir Dis (1987) 1.13
Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy. Tuber Lung Dis (1997) 1.13
Bacteremia with upper gastrointestinal endoscopy. Ann Intern Med (1975) 1.13
Antigen responsiveness during tuberculosis: regulatory interactions of T cell subpopulations and adherent cells. J Lab Clin Med (1987) 1.12
Role of arginase in killing of schistosomula of Schistosoma mansoni. J Exp Med (1980) 1.12
Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial. J Infect Dis (1996) 1.12
Immunobiology and species distribution of Mycobacterium tuberculosis antigen 5. Infect Immun (1979) 1.10
Dyscoordinate expression of tumor necrosis factor-alpha by human blood monocytes and alveolar macrophages. Am Rev Respir Dis (1989) 1.08
Identification of antigens of Mycobacterium tuberculosis using human monoclonal antibodies. J Clin Invest (1989) 1.08
Evidence against a role for interleukin-10 in the regulation of growth of Mycobacterium avium in human monocytes. J Infect Dis (1996) 1.08
Selective increases in antibody isotypes and immunoglobulin G subclass responses to secreted antigens in tuberculosis patients and healthy household contacts of the patients. Clin Diagn Lab Immunol (1995) 1.08
Cofactors of progression to acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. Am J Epidemiol (1990) 1.07